Leukemia med may also fight ovarian cancer

LOS ANGELES, Nov. 12 (UPI) --

U.S. medical scientists say they've discovered the drug Sprycel, approved for chronic myeloid leukemia, also is effective against ovarian cancer cells.

Researchers at UCLA's Jonsson Comprehensive Cancer Center say they found Sprycel significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death. In addition, the scientists said the drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian cancer.

Assistant Professor Gottfried Konecny, first author of the study, said.

The study appears in British Medical Journal.

Copyright 2009 by United Press International
All Rights Reserved.